06 Sep 2023

Notice of Results

Investors

21 Jul 2023

Issue of Equity and Total Voting Rights

Investors

28 Jun 2023

Result of Annual General Meeting

Investors

28 Jun 2023

Annual General Meeting and Shareholder Event

Investors

21 Jun 2023

Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study

Investors | Therapeutics

19 Jun 2023

Director Appointment

Investors

19 Jun 2023

Statement regarding market speculation

Investors

08 Jun 2023

Avacta Annual General Meeting and Shareholder Event Detailed Agenda

Investors

05 Jun 2023

Avacta Achieves Second Milestone in AffyXell Joint Venture Triggering Increased Equity Stake

Investors | Therapeutics

02 Jun 2023

Posting of Annual Report and Notice of AGM

Investors